TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Argent Biopharma ( (AU:RGT) ) just unveiled an update.
Argent Biopharma Limited has announced a proposed issue of 25 million ordinary fully paid securities, with the issuance date set for October 14, 2025. This move is part of a placement or other type of issue, aimed at enhancing the company’s capital structure and potentially expanding its market presence.
More about Argent Biopharma
Argent Biopharma Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of pharmaceutical products. The company is listed on the Australian Securities Exchange (ASX) under the issuer code RGT.
Average Trading Volume: 52,294
Technical Sentiment Signal: Sell
Current Market Cap: A$4.94M
For a thorough assessment of RGT stock, go to TipRanks’ Stock Analysis page.